Xinhua reported on a breast cancer study from researchers at UBC, Washington University School of Medicine and the Baylor College of Medicine.
Researchers were able to link some DNA mutations to a high risk of relapse in estrogen receptor positive breast cancer and other mutations with the opposite effect.
